Can health insurance coverage explain the generic competition paradox?

Economics Letters

Volumn 101, Issue 1, 2008, Pages 48-52

  Ferrara, Ida ^a   Kong, Ying ^a  

^a YORK UNIVERSITY   (Canada)

Author keywords

Brand name pricing; Generic competition paradox; Generic entry; Health insurance

Indexed keywords

EID: 49949085180     PISSN: 01651765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.econlet.2008.04.011     Document Type: Article

References (9)

1. Frank R.G., and Salkever D.S. Pricing patent loss and the market for pharmaceuticals. Southern Economic Journal 59 2 (1992) 165-179
2. Frank R.G., and Salkever D.S. Generic entry and the pricing of pharmaceuticals. Journal of Economics and Management Strategy 6 1 (1997) 75-90
3. Grabowski H.G., and Vernon J.M. Brand loyalty, entry and price competition in pharmaceuticals after the 1984 Drug Act. Journal of Law and Economics 35 2 (1992) 331-350
4. Hellerstein J.K. The Demand for Post-Patent Prescription Pharmaceuticals. NBER Working Paper vol. 4981 (1994)
5. Kong Y. The price premium of generic pharmaceuticals to brand-names and pharmaceutical price index. Applied Economics 36 7 (2004) 731-737
6. Pavcnik N. Do pharmaceutical prices respond to potential patient out-of-pocket expenses?. Rand Journal of Economics 33 3 (2002) 469-487
7. Scherer F.M. Pricing, profits, and technological progress in the pharmaceutical industry. Journal of Economic Perspectives 7 3 (1993) 95-115
8. Wagner J.L., and Duffy B.M. Containing the costs of prescription drugs: the U.S. experience. Paper Presented at the Symposium: Controlling Costs While Maintaining Health, Bonn (1988)
9. Wiggins S.N., and Maness R. Price competition in pharmaceutical markets: the case of anti-infectives. Economic Inquiry 42 2 (2004) 247-263